HIL
Hills Limited
1 day chart
About HIL
Buy Australian shares starting with HIL. Invest today with a CHESS-sponsored investing platform!
Sector
Information Technology
CEO
-
Industry
Electronic Equipment, Instruments & Components
Website
-
$12M
-0.22
0.00%
$0.02
$0.02
$0.02
-
-
Announcements
What does Hills Limited (HIL) do and how does it make money?
It started with the iconic Hills Hoist. Over the decades, Hills Limited became a supplier of technology solutions to the healthcare, security and IT industries in Australia and New Zealand.
The company operates and earns revenue through two segments, Hills Health Solutions and Hills Distribution.
Via Health Solutions, Hills designs, supplies and installs health technology solutions in hospitals and aged care facilities, in particular nurse call and patient engagement systems. Hills also carries out research and development activities.
Through Distribution, Hills provides security and IT solutions for commercial, infrastructure, government and transport industry customers. Some of these solutions include video and surveillance systems, access control and intrusion protection, WiFi and firewall solutions. The Distribution segment also sources and manages over 350 contractors to provide pre and post installation support in residential and commercial settings.
Hills was founded in Adelaide, South Australia in 1945 but is currently headquartered in Lidcombe, New South Wales.
Is Hills Limited a profitable company?
No, Hills is not a profitable company. In FY2021, it recorded a net profit after tax loss of A$10.2m. Net profits have also consistently been negative since FY2015.
The company’s revenue has shrunk every year since 2012 at an average rate of negative 18.06%.
As of FY2021, Hills has accumulated a negative free cash flow of A$2m and a net debt of A$13.2m.
Is HIL stock a buy?
Hills Limited has been heavily hit by COVID-19. As of the company’s latest half-yearly report, projects within Health Solutions and Distribution segments have been delayed due to health restrictions and supply chain disruptions. As a result, HIL stock has nosedived. Between October 2021 and April 2022 the stock dropped 40% from A$0.16 down to A$0.09. Some investors are avoiding HIL stock due to continuing COVID related problems and the weakness of Hills’ financials. However, others are optimistic as Hills has just won projects with ACT Health, Calvary Health, Westmead Private Hospital, Sunshine Hospital, Churches of Christ, KawekaHealth NZ and Concord Hospital. The underlying demand for Hills products also continues to be strong.
How do I buy HIL stock?
Stake offers a quick and easy way to purchase HIL shares – along with 2,000+ other Australian stocks and ASX ETFs – for a brokerage fee of only A$3.
Stake is CHESS sponsored, meaning that when you invest in shares on the ASX, you get a HIN (Holder Identification Number) and stocks are held in your name.
With Stake, you can be in the market in under 5 minutes, whether it's the ASX or Wall St. If you’re interested in building your portfolio by adding HIL, sign up today.
Does HIL stock pay dividends?
Hills Limited have not paid a dividend since April 2015. The company has not made any announcements to do so in the near future.
Who owns HIL stock?
The general public holds the majority of HIL stock at 56.3% of the float.
Private companies come in second with ownership of 31.2% of the float. Some of these companies include Hills Associates Limited (7.48%), Poplar Pty Limited (7.39%), Greybox Holdings (3.18%), Cariste Pty Ltd (2.97%), Ace Property Holdings Proprietary Limited (2.68%) and Jacaranda Pastoral Pty. Ltd. (2.53%).
Non-executive director Kenneth Dwyer and Senior Key Executive Andy Hall hold 0.39% and 0.29%, respectively.
HIL FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in HIL
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.